… Several randomized control trials have shown non-inferior clinical outcomes of transcatheter
aortic valve implantation (TAVI) compared to surgical aortic valve replacement for the …

… Of 174 patients undergoing transfemoral transcatheter aortic valve implantation (TAVI) at
our … Our study is the first to compare the repositionable DFM valve with the third generation …

… Third, different inclusion criteria (eg more moderate risk patients), types of valves implanted,
baseline characteristic, access routes and sample sizes are important variables that may …

… Implantation success was defined as 1 valve implanted at the intended site by 1 attempted
procedure. Outcomes measured in the SOURCE 3 Registry were all-cause death, cardiac …

… aortic valve implantation, the third-generation balloon-expandable S3 prosthesis substantially
reduces post-TAVI aortic regurgitation compared to the second-generation SXT. Its use …

… third generation of the CoreValve prosthesis were implanted in 10, 24, and 102 consecutive
high-risk patients (logistic EuroScore: 23.1 15.0%) with severe symptomatic aortic valve …

… Until now, potential financial benefits of third generation valve … implantation rates in described
third generation valve models [9]… generation valve models, overall pacemaker implantation …

Objectives Chronic renal failure is common in patients referred for transcatheter aortic valve
implantation (TAVI). CT angiography is recommended and provides crucial information prior …

… implantation of a balloon-expandable aortic valve prosthesis with encouraging results.
Nevertheless, the primarily used antegrade approach for valve implantation … valve implantation, a …

… Improvements in patient selection, imaging, and second and third generation devices have
decreased the incidence of PVLs and vascular complications that followed the earliest TAVI …